China is considering a potential emergency approval of BioNTech SE’s Covid-19 vaccine to make it available to foreigners living in the country, the company’s Chief Operating Officer Sierk Poetting said.
Government-level discussions are still at an early stage and BioNTech hasn’t been involved yet, Poetting said on the sidelines of a conference in Singapore Monday. The company has submitted all the data necessary to Chinese authorities for its discretion, he said, adding there hasn’t been a timetable for a potential approval yet.
